Morbidity and Mortality Weekly Report (MMWR)

June 14, 2013 / Vol. 62 / No. RR–4
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013: Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)

In October 2012, the Advisory Committee on Immunization Practices (ACIP) adopted revised recommendations for prevention of measles, rubella, congenital rubella syndrome (CRS), and mumps. During 1998–2006, ACIP made new and revised recommendations for measles, rubella, and mumps. The recommendations were published among Recommendations and Reports and weekly reports in the MMWR. This report summarizes the updates and replacements to previous recommendations by ACIP regarding the following topics: the use of measles, mumps, and rubella vaccine for prevention and control of measles, mumps, and rubella; the rubella vaccine and pregnancy; and, control and elimination of mumps.

May 31, 2013 / Vol. 62 / No. SS–1
Surveillance for Certain Health Behaviors Among States and Selected Local Areas — United States, 2010

The Behavioral Risk Factor Surveillance System (BRFSS) is an ongoing, state-based, random-digit–dialed telephone survey of noninstitutionalized adults aged ≥18 years residing in the United States. BRFSS collects data on health-risk behaviors, chronic diseases and conditions, access to health care, and use of preventive health services and practices related to the leading causes of death and disabilities in the United States. This report presents results for 2010 for all 50 states, the District of Columbia, the Commonwealth of Puerto Rico, Guam, the U.S. Virgin Islands, 192 MMSAs, and 302 counties. In 2010, the estimated prevalence of high-risk health behaviors, chronic diseases and conditions, access to health care, and use of preventive health services varied substantially by state and territory, MMSA, and county.

June 1, 2012 / Vol. 59 / No. 53
Summary of Notifiable Diseases — United States, 2010

Health-care providers in the United States are required to report certain infectious diseases to a specified state or local authority. A disease is designated as notifiable if timely information about individual cases is considered necessary for prevention and control of the disease. Each year, CDC publishes a summary of the cases of notifiable disease reported for the most recent year for which data is available. This report presents a summary of notifiable diseases for 2010.

May 17, 2013 / Vol. 62 / Supplement / No. 2
Mental Health Surveillance Among Children — United States, 2005–2011

This report summarizes information about ongoing federal surveillance systems that can provide estimates of the prevalence of mental disorders and indicators of mental health among children living in the United States and presents estimates of childhood mental disorders and indicators from these systems during 2005–2011. Attention-deficit/hyperactivity disorder (6.8%) was the most prevalent parent-reported current diagnosis among children aged 3–17 years, followed by behavioral or conduct problems (3.5%), anxiety (3.0%), depression (2.1%), autism spectrum disorders (1.1%), and Tourette syndrome (0.2% among children aged 6–17 years). An estimated 4.7% of adolescents aged 12–17 years reported an illicit drug use disorder in the past year, 4.2% had an alcohol abuse disorder in the past year, and 2.8% had cigarette dependence in the past month. The overall suicide rate for persons aged 10–19 years was 4.5 suicides per 100,000 persons in 2010. Approximately 8% of adolescents aged 12–17 years reported ≥14 mentally unhealthy days in the past month.

February 1, 2013 / Vol. 62
Advisory Committee on Immunization Practices (ACIP) Recommended Immunization Schedules for Persons Aged 0 Through 18 Years and Adults Aged 19 Years and Older — United States, 2013

Each year, recommendations for routine use of vaccines in children, adolescents, and adults in the United States are developed by the Advisory Committee on Immunization Practices (ACIP). This year, for the first time, recommended immunization schedules for persons aged 0 through 18 years and adults aged 19 years and older are being published together. Health-care providers are advised to use both the recommended schedules for children and adults in combination with their footnotes and not as stand-alones. For guidance on the use of all the vaccines in the schedules, including contraindications and precautions to use of a vaccine, providers are referred to the respective ACIP vaccine recommendations.